Terns Pharmaceuticals, Inc.
TERN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $440,469 | $462,471 | $366,816 | $178,654 |
| - Cash | $161,439 | $79,926 | $143,235 | $47,699 |
| + Debt | $1,347 | $603 | $1,205 | $0 |
| Enterprise Value | $280,377 | $383,148 | $224,786 | $130,955 |
| Revenue | $0 | $0 | $0 | $1,000 |
| % Growth | – | – | -100% | – |
| Gross Profit | $0 | $0 | $0 | $1,000 |
| % Margin | – | – | – | 100% |
| EBITDA | -$100,975 | -$101,677 | -$60,997 | -$49,348 |
| % Margin | – | – | – | -4,934.8% |
| Net Income | -$88,853 | -$90,210 | -$60,345 | -$50,158 |
| % Margin | – | – | – | -5,015.8% |
| EPS Diluted | -1.12 | -1.27 | -1.67 | -1.98 |
| % Growth | 11.8% | 24% | 15.7% | – |
| Operating Cash Flow | -$70,016 | -$67,390 | -$49,109 | -$41,827 |
| Capital Expenditures | -$42 | -$52 | -$275 | -$340 |
| Free Cash Flow | -$70,058 | -$67,442 | -$49,384 | -$42,167 |